Home - Arizona Pharmacy Association

AzPA Fall Conference

SEPTEMBER 14, 2019 | SCOTTSDALE, AZ

Earn 8.0 hours of continuing education including immunization, law and opioid CE sessions while interacting with physicians, endocrinologists, nurse practitioners, physician assistants, registered nurses, pharmacists, diabetes educators, registered dietitians, and other healthcare professionals who care for patients with type 2 diabetes mellitus (T2DM).

Learn More

APhA Pharmacist and Patient-Centered Diabetes Care Certificate Program

AUGUST 24, 2019 | PHOENIX, AZ

Gain experience evaluating and adjusting drug therapy regimens for patients with type 1 & type 2 diabetes, counseling patients about lifestyle interventions, analyzing and interpreting self-monitoring of blood glucose results, and assessing the overall health status of patients to identify needed monitoring and interventions.

Learn More

Immunization Certificate Program

SEPTEMBER 27TH| TUCSON, AZ
OCTOBER 19TH | GLENDALE

An innovative and interactive educational program that provides pharmacists and student pharmacists with the skills necessary to become primary sources for vaccine advocacy, education, and administration. The two-part program reviews the basics of immunology, identifies legal and regulatory issues pharmacists must consider before starting an immunization program.

LEARN MORE

Educate

Businessman hand holding the futuristic network connection techn

Learn with us

Advocate

Discover your voice

Connect

Get involved! Serve on a team

Connect with us.

Pharmacy Flash

AzPA Pharmacy Flash

Independent community pharmacy plays a vital role in healthcare
Depending on who you talk to, there are roughly 25,000 small chain and independent pharmacies in the United States. Some of these are small family-owned chains like the Marquess Group, with 10 locations in Georgia. But most are single-location pharmacies operated by a pharmacist owner.
Should community pharmacies have prescribing power for the treatment of lyme disease?
Lyme disease, a vector-borne illness caused by the bacteria Borrelia burgdorferi, is transmitted to humans by deer ticks.
FDA assessing data manipulation concerns with gene therapy product
Officials with the FDA issued a statement to clarify data accuracy issues with recently-approved gene therapy Zolgensma (onasemnogene abeparvovec-xioi, AveXis), a product intended to treat spinal muscular atrophy (SMA) in children under 2 years old.